Literature DB >> 9540332

Association of a dolichoectatic middle cerebral artery and an intracranial cavernous hemangioma--case report.

Y Kanemoto1, M Hisanaga, H Bessho.   

Abstract

A normotensive, non-smoking 41-year-old female with a history of generalized seizures from the age of 4 years presented with a left middle cerebral artery (MCA) fusiform aneurysm and an ipsilateral frontal lobe cavernous hemangioma. Surgical exploration demonstrated that the fusiform aneurysm-like lesion was a dolichoectatic MCA with no arteriosclerotic change. The pathogenesis of dolichoectasia is obscure, but the association of a dolichoectatic MCA and an intracranial cavernous hemangioma is suggestive of congenital factors.

Entities:  

Mesh:

Year:  1998        PMID: 9540332     DOI: 10.2176/nmc.38.40

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  5 in total

Review 1.  Dolichoectasia-an evolving arterial disease.

Authors:  Jose Gutierrez; Ralph L Sacco; Clinton B Wright
Journal:  Nat Rev Neurol       Date:  2011-01       Impact factor: 42.937

2.  Cerebral Revascularization for the Management of Symptomatic Pure Arterial Malformations.

Authors:  Xiaocheng Lu; Xinggen Fang; Yabo Huang; Peng Zhou; Zhong Wang; Waleed Brinjikji; Gang Chen
Journal:  Front Neurol       Date:  2021-12-16       Impact factor: 4.003

Review 3.  Intracranial Arterial Dolichoectasia.

Authors:  Victor J Del Brutto; Jorge G Ortiz; José Biller
Journal:  Front Neurol       Date:  2017-07-17       Impact factor: 4.003

4.  A 5-Year Follow-up of Intracranial Arterial Dolichoectasia: A Case Report and Review of Literature.

Authors:  Lavlesh Rathore; Yashiro Yamada; Tsukasa Kawase; Yoko Kato; Satya Bhusan Senapati
Journal:  Asian J Neurosurg       Date:  2019-11-25

Review 5.  Diagnosis and treatment of pure arterial malformation: Three case reports and literature review.

Authors:  Tian-Yi Liu; Ning Xu; Zheng Wan; Zhe-Ming Zhang; Jian-Jun Xu; Hao Meng; Hong-Lei Wang
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.